56.50
Bridgebio Pharma Inc Aktie (BBIO) Neueste Nachrichten
Sentiment analysis tools applied to BridgeBio Pharma Inc.July 2025 Institutional & Technical Buy Zone Confirmation - newser.com
BridgeBio Pharma Hits New 52-Week High of $56.24, Up 101% Yearly - Markets Mojo
BridgeBio Pharma stock hits 52-week high at 56.28 USD - Investing.com
Will BridgeBio Pharma Inc. bounce back from current support2025 Market Outlook & Expert Curated Trade Setups - newser.com
BridgeBio Pharma Inc. stock trend outlook and recovery pathWeekly Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Long term hold vs stop loss in BridgeBio Pharma Inc.Trade Exit Summary & Verified Short-Term Plans - newser.com
How buybacks impact BridgeBio Pharma Inc. stock valueInsider Selling & Daily Market Momentum Tracking - newser.com
BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unlocking Potential with a 19.51% Upside and Revolutionary Biotech Ventures - DirectorsTalk Interviews
What indicators show strength in BridgeBio Pharma Inc.Index Update & Reliable Price Breakout Alerts - newser.com
BridgeBio Pharma Hits New 52-Week High of $55.13, Up 94.83% - Markets Mojo
BridgeBio (BBIO) Leads Biotech Sector with Promising Pipeline - GuruFocus
SA Asks: What's the most attractive biotech stock right now? - Seeking Alpha
Oak Ridge Investments LLC Purchases New Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat
Published on: 2025-10-12 03:32:49 - newser.com
BridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 40,000 Shares - MarketBeat
Using flow based indicators on BridgeBio Pharma Inc.2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com
Why BridgeBio Pharma Inc. (2CL) stock could outperform next yearJuly 2025 Breakouts & AI Based Trade Execution Alerts - newser.com
BridgeBio Pharma (NASDAQ:BBIO) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
BridgeBio Pharma Hits New 52-Week High of $55.33, Up 98.71% - Markets Mojo
Using economic indicators to assess BridgeBio Pharma Inc. potentialJuly 2025 Intraday Action & Daily Chart Pattern Signals - newser.com
Leading vs lagging indicators on BridgeBio Pharma Inc. performance2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
Real time breakdown of BridgeBio Pharma Inc. stock performanceIPO Watch & Risk Managed Investment Signals - newser.com
Will breakout in BridgeBio Pharma Inc. lead to full recoveryJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
BridgeBio Pharma, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
BridgeBio Pharma Hits New 52-Week High of $54.64, Up 96.23% - Markets Mojo
BridgeBio Pharma (NASDAQ:BBIO) Sets New 12-Month HighHere's What Happened - MarketBeat
BridgeBio Pharma stock hits 52-week high at $54.61 By Investing.com - Investing.com South Africa
BridgeBio Pharma stock hits 52-week high at $54.61 - Investing.com
Analyzing drawdowns of BridgeBio Pharma Inc. with statistical toolsJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - newser.com
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - MarketScreener
PFG Investments LLC Takes Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat
What MACD and RSI say about BridgeBio Pharma Inc.Weekly Market Outlook & Target Return Focused Stock Picks - newser.com
Pattern recognition hints at BridgeBio Pharma Inc. upsideJuly 2025 EndofMonth & Pattern Based Trade Signal System - newser.com
BridgeBio Pharma (BBIO) Is Up 5.6% After Acoramidis Shows Broad ATTR-CM Benefit in Phase 3 Data - Yahoo
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
BridgeBio Pharma reports inducement grants under Nasdaq Listing Rule - MarketScreener
23,884 RSUs: BridgeBio Grants Inducement Shares with Quarterly Vesting Starting Nov. 16, 2026 - Stock Titan
What earnings revisions data tells us about BridgeBio Pharma Inc.2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com
How big funds are accumulating BridgeBio Pharma Inc. (2CL) stockJuly 2025 Summary & Low Drawdown Trading Strategies - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):